Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Autor: Weller, M, Butowski, N, Tran, DD, Recht, LD, Lim, M, Hirte, H, Ashby, L, Mechtler, L, Goldlust, SA, Iwamoto, F, Drappatz, J, O'Rourke, DM, Wong, M, Hamilton, MG, Finocchiaro, G, Perry, J, Wick, W, Green, J, He, Y, Turner, CD, Yellin, MJ, Keler, T, Davis, TA, Stupp, R, Sampson, JH, Campian, J, Recht, L, Goldlust, S, Becker, K, Barnett, G, Nicholas, G, Desjardins, A, Benkers, T, Wagle, N, Groves, M, Kesari, S, Horvath, Z, Merrell, R, Curry, R, O'Rourke, J, Schuster, D, Mrugala, M, Jensen, R, Trusheim, J, Lesser, G, Belanger, K, Sloan, A, Purow, B, Fink, K, Raizer, J, Schulder, M, Nair, S, Peak, S, Brandes, A, Mohile, N, Landolfi, J, Olson, J, Jennens, R, DeSouza, P, Robinson, B, Crittenden, M, Shih, K, Flowers, A, Ong, S, Connelly, J, Hadjipanayis, C, Giglio, P, Mott, F, Mathieu, D, Lessard, N, Sepulveda, SJ, Lövey, J, Wheeler, H, Inglis, PL, Hardie, C, Bota, D, Lesniak, M, Portnow, J, Frankel, B, Junck, L, Thompson, R, Berk, L, McGhie, J, Macdonald, D, Saran, F, Soffietti, R, Blumenthal, D, André de, SBCM, Nowak, A

Publikováno v: Weller, M; Butowski, N; Tran, DD; Recht, LD; Lim, M; Hirte, H; et al.(2017). Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. The Lancet Oncology, 18(10), 1373-1385. doi: 10.1016/S1470-2045(17)30517-X. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2sg9m5wp

© 2017 Elsevier Ltd Background Rindopepimut (also known as CDX-110), a vaccine targeting the EGFR deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet haemocyanin. In the ACT IV study, we aimed to assess

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::6bdef254233643727bdc6e1e7e8761af
http://www.escholarship.org/uc/item/2sg9m5wp

Impacts of Dams and Global Warming on Fish Biodiversity in the Indo-Burma Hotspot

Autor: Suvarnaraksha, A, Tanaka, K, Grudpan, J, Grudpan, C, Watanabe, K, Dudgeon, D, Kano, Y, Thach, P, Tran, DD, Yamashita, T, Utsugi, K, Doi, H, Shimatani, Y, Shibukawa, K, Samejima, H, Sato, T, Praxaysonbath, B, Nguyen, PT, Musikasinthorn, P, Magtoon, W, Nam, S

Publikováno v: PLoS ONE, Vol 11, Iss 8, p e0160151 (2016)
PLoS ONE

Both hydropower dams and global warming pose threats to freshwater fish diversity. While the extent of global warming may be reduced by a shift towards energy generation by large dams in order to reduce fossil-fuel use, such dams profoundly modify ri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::643bd0eb04c272ac3bc2c8655fd9c3a7
http://hdl.handle.net/10722/245857

Clinical Practice Experience With NovoTTF-100A (TM) System for Glioblastoma: The Patient Registry Dataset (PRiDe)

Autor: Mrugala, MM, Engelhard, HH, Tran, DD, Kew, Y, Cavaliere, R, Villano, JL, Bota, DA, Rudnick, J, Sumrall, AL, Zhu, J-J, Butowski, N

Publikováno v: Mrugala, MM; Engelhard, HH; Tran, DD; Kew, Y; Cavaliere, R; Villano, JL; et al.(2014). Clinical Practice Experience With NovoTTF-100A (TM) System for Glioblastoma: The Patient Registry Dataset (PRiDe). SEMINARS IN ONCOLOGY, 41, S4-S13. doi: 10.1053/j.seminoncol.2014.09.010. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/60k8f1mq

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::869d2ff3ff6d3b1de23020635a6189c7
http://www.escholarship.org/uc/item/60k8f1mq

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.